chiral resolution

R&D

A closer look at how controlled crystallisation and complementary approaches can be used to efficiently separate and purify chiral molecules.

News

In its third big licensing deal of the week, Eli Lilly has tapped RNA-editing specialist Ascidian for kidney disease therapies in a $1.9bn alliance.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.